Question

Difficulty: MediumDepressive Disorders

A 32-year-old woman is evaluated in the psychiatry clinic for ongoing management of major depressive disorder. She initially presented two years ago with a 3-month history of pervasive sadness, anhedonia, significant weight loss, and severe insomnia leading to functional impairment at work. Over the course of her illness, she has required progressive escalation of her treatment regimen due to inadequate responses. Arrange the following therapeutic interventions in the generally accepted chronological sequence that her physician would have followed, from initial diagnosis to the management of severe, treatment-resistant symptoms.

  1. 1Initiation of a selective serotonin reuptake inhibitor (SSRI)
  2. 2Switch to a serotonin-norepinephrine reuptake inhibitor (SNRI) monotherapy
  3. 3Augmentation with an atypical antipsychotic
  4. 4Referral for electroconvulsive therapy (ECT)

Answer

The correct sequence is: Initiation of an SSRI -> Switch to an SNRI monotherapy -> Augmentation with an atypical antipsychotic -> Referral for electroconvulsive therapy (ECT).
The standard stepped-care algorithm for major depressive disorder dictates starting with a single first-line agent, typically an SSRI. If the patient exhibits no response after an adequate trial, switching to a different monotherapy (such as an SNRI) is indicated. If there is persistent non-response or only a partial response after multiple sequential monotherapy trials, augmentation with an atypical antipsychotic, lithium, or a second antidepressant is appropriate. Finally, if the depression remains severely treatment-resistant despite these medication combinations, neuromodulation therapies such as electroconvulsive therapy (ECT) are considered.

Step-by-Step Solution

1
Identify the first-line treatment for a new diagnosis of major depressive disorder.
Initiation of an SSRI.
SSRIs have a favorable side effect profile and proven efficacy, making them the standard initial choice.
2
Determine the appropriate management for an initial medication non-response.
Switch to an SNRI monotherapy.
When a patient shows no clinical response to a first-line agent, the standard algorithm recommends switching to a different monotherapy rather than immediately adding medications.
3
Select the strategy for continued non-response or partial response after multiple monotherapy trials.
Augmentation with an atypical antipsychotic.
Adding a second medication with a different mechanism of action is appropriate when monotherapies have been exhausted or yield insufficient improvement.
4
Identify the ultimate intervention for severe, refractory cases.
Referral for electroconvulsive therapy (ECT).
ECT is highly effective and is utilized when patients remain severely symptomatic despite multiple combination pharmacological regimens.

Key Concept

Stepped-care pharmacological escalation for major depressive disorder
Estimated Time:1m 30s
Rate this question